• Return to Headlines

Anthera Pharmace has the Lowest Return on Equity in the Biotechnology Industry (ANTH, CHRS, TTOO, IRWD, RGLS)

By David Diaz

Below are the three companies in the Biotechnology industry with the lowest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and are growing.

Anthera Pharmace ranks lowest with a ROE of -92,126.0%. Coherus Bioscien is next with a ROE of -59,511.2%. T2 Biosystems ranks third lowest with a ROE of -30,693.7%.

Ironwood Pharmac follows with a ROE of -30,546.2%, and Regulus Therapeu rounds out the bottom five with a ROE of -22,046.9%.

SmarTrend is tracking the current trend status for Regulus Therapeu and will alert subscribers who have RGLS in their portfolio or watchlist when shares have changed trend direction.

Keywords: lowest return on equity anthera pharmace coherus bioscien t2 biosystems ironwood pharmac regulus therapeu

Ticker(s): ANTH CHRS TTOO IRWD RGLS